What is the recommended treatment with Tetanus Immune Globulin (TIG) for individuals at risk of tetanus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tetanus Immune Globulin (TIG) Treatment Recommendations

For tetanus prophylaxis, Tetanus Immune Globulin (TIG) at a dose of 250 units intramuscularly is recommended for individuals with wounds other than clean minor wounds who have unknown/uncertain tetanus vaccination history or fewer than 3 previous tetanus toxoid doses. 1, 2

Wound Management and TIG Indications

The decision to administer TIG depends on both wound characteristics and vaccination history:

Wound Classification:

  • Clean, minor wounds: TIG not required regardless of vaccination history
  • All other wounds (contaminated with dirt, feces, soil, saliva; puncture wounds; avulsions; wounds from crushing, burns, frostbite): TIG indicated for those with incomplete vaccination 3, 2

Vaccination History Assessment:

Previous Tetanus Doses Clean, Minor Wounds All Other Wounds
Unknown or <3 doses No TIG needed TIG required
≥3 doses No TIG needed No TIG needed

Administration Guidelines

  • Standard prophylactic dose: 250 units administered intramuscularly as a single dose 1, 2
  • Children <7 years: Can calculate by body weight (4.0 units/kg), though administering the full 250 units is often advised regardless of size 2
  • Concurrent vaccination: When both TIG and tetanus toxoid-containing vaccine are indicated:
    • Administer using separate syringes
    • Inject at different anatomical sites
    • Use age-appropriate vaccine (DTaP for <7 years, Td for 7-10 years, Tdap for ≥11 years) 1, 2

Special Populations

  • Immunocompromised patients: Should receive TIG for contaminated wounds regardless of vaccination history 1
  • Pregnant women: Should receive Tdap if tetanus prophylaxis is indicated 1
  • Contraindications to tetanus toxoid: If a person cannot receive tetanus toxoid and has a tetanus-prone wound, administer only TIG for passive immunization 3, 2

Treatment of Active Tetanus

While primarily used for prophylaxis, TIG is also indicated in the treatment of active tetanus:

  • Dosage should be adjusted according to infection severity 2
  • Some evidence suggests intrathecal administration of TIG may be more effective than intramuscular administration in treating active tetanus 4, 5

Important Clinical Considerations

  • Proper wound cleaning is paramount for tetanus prevention, with TIG serving as adjunctive therapy 2
  • Even with adequate immunization, tetanus can rarely occur in vaccinated individuals, as demonstrated by case reports of patients with protective antibody levels who still developed tetanus 6
  • No significant increase in tetanus antitoxin levels occurs within the first 4 days following a booster dose, supporting the need for TIG in high-risk wounds even among previously vaccinated individuals whose last dose was >5-10 years ago 7

Pitfalls to Avoid

  • Do not assume military service guarantees complete tetanus vaccination series 2
  • Do not withhold TIG in patients with tetanus-prone wounds and uncertain vaccination history 2
  • Do not administer TIG and tetanus toxoid at the same anatomical site 1, 2
  • Do not forget that approximately 10% of tetanus cases have no identifiable wound or breach in skin/mucous membrane 2

References

Guideline

Tetanus Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Elevated antitoxin titers in a man with generalized tetanus.

The Journal of family practice, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.